The hypothesis of the study was that participants with MHLW-MetS or high risk for MHLW-MetS in the PSMetS group would exhibit larger reductions in one or more of the MHLW-MetS risk factors for MHLW-MetS (R1 to R5), compared with the usual care group, 1 year after the randomisation.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.